Adma Biologics Inc (ADMA)

R&D Expenses

$11.52M

TTM · Period ending: · USD

ADMA logo

ADMA R&D Expenses

Latest reported$11.52M
ADMA TTM R&D Expenses ($0.00 → $11.52M)
High-resolution chart · PNG

ADMA r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Adma Biologics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
11,515,000
6,532,000
4,761,000
3,776,000
2,660,000
2,189,000
1,813,000
1,867,486
2,051,486
2,894,486
3,299,486
3,928,320
4,374,267
3,844,653
3,613,764
3,268,432
2,997,042
3,282,522
3,646,060
3,930,536
4,868,370
5,365,924
5,907,013
5,358,372
4,141,385
3,001,951
2,343,848
1,734,105
2,559,935
3,515,049
3,926,120
5,935,422
6,432,257
6,318,566
6,229,587
4,948,579
4,811,773
6,853,253
7,688,238
9,101,672
9,535,914
7,641,934
7,015,945
6,938,856
6,310,280
6,588,280
9,517,014
10,553,448
10,479,509
12,165,950
9,303,077
7,614,871
8,146,518
4,854,842
3,469,078
2,201,131
260,494
81,820
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.